EUVIMEDSkopri EUVIMED
Randomisierte kontrollierte StudieOpen access

Effects of the neuroactive steroid precursor pregnenolone on stress- and alcohol cue–provoked pain responses in individuals with alcohol use disorder.

Riley Quinlan, Huaze Gao, Rajita Sinha, Verica Milivojevic iD

Experimental and Clinical Psychopharmacology · 2026

DOI: 10.1037/pha0000862 ↗

At a glance

Randomisierte kontrollierte Studie in Experimental and Clinical Psychopharmacology, 2026. Written by Riley Quinlan and 3 co-authors. Institution: Department of Psychiatry, Yale Stress Center, Yale University School of Medicine. Major MEDLINE topics: Pregnenolone, Stress, Psychological, Alcoholism, Pain. The full text is freely available in PubMed Central. Funded by: NIDA NIH HHS, National Institutes of Health; National Institute on Alcohol Abuse and Alcoholism, NIAAA NIH HHS.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Chronic alcohol use reduces GABAergic activity and neuroactive steroid levels, contributing to stress response dysregulation and heightened pain sensitivity in individuals with alcohol use disorder (AUD). Neuroactive steroid precursor pregnenolone (PREG) reduces stress- and cue-related craving and anxiety responses in individuals with AUD, but its effects on pain responses in AUD have not been assessed. Sixty treatment-seeking men and women with AUD in an 8-week randomized trial receiving placebo (PBO; n = 21), 300 mg PREG/day (n = 21), or 500 mg PREG/day (n = 18) completed a 3-day script-guided imagery provocation in Week 2. Following exposure to stress (S), alcohol cue (C), and neutral (N) conditions (administered across three separate laboratory days in a counterbalanced order), participants provided self-reports of pain, craving, and anxiety before, immediately after, and at various time points following the provocation. Analyses utilized a mixed factorial design with medication as a between-subjects factor and imagery condition and time point as within-subjects factors. The 300-mg PREG group did not exhibit significant increases in stress- or cue-induced pain compared with neutral condition (S:N: p = .705; C:N: p = .705), whereas increases in stress-induced pain in PBO (S > N: p = .009; C:N: p = .152) and stress- and cue-induced pain in the 500-mg PREG group (S > N: p N: p = .002) were observed. Pain was associated with alcohol craving (p < .001) and anxiety (p < .001). A PREG treatment effect showed positive associations between pain and alcohol craving in the PREG groups (300 mg: p < .001; 500 mg: p < .001) but not PBO (p = .962) and positive associations between pain and anxiety in the 300-mg PREG group (300 mg: p < .001) but not the PBO or 500-mg PREG groups (PBO: p = .325; 500 mg: p = .213). PREG dose specifically reduced stress-provoked pain responses and affected concurrent pain and craving and anxiety associations, warranting further examination of PREG effects on pain and alcohol use outcomes in AUD. (PsycInfo Database Record (c) 2026 APA, all rights reserved).

Subjects

MeSH terms (MEDLINE)

PregnenoloneStress, PsychologicalAlcoholismPainHumansMaleCuesFemaleCravingAdultAnxietyMiddle AgedPain Measurement

Substances

Pregnenolone

Authors and institutions

  • Department of Psychiatry, Yale Stress Center, Yale University School of Medicine.

ORCID profiles: Verica Milivojevic

Funding

  • NIDA NIH HHS
  • National Institutes of Health; National Institute on Alcohol Abuse and Alcoholism
  • NIAAA NIH HHS
  • National Institutes of Health; National Institute on Drug Abuse
  • National Institutes of Health

Cite

APA

Quinlan, R., Gao, H., Sinha, R., & Milivojevic, V. (2026). Effects of the neuroactive steroid precursor pregnenolone on stress- and alcohol cue–provoked pain responses in individuals with alcohol use disorder. Experimental and Clinical Psychopharmacology. https://doi.org/10.1037/pha0000862

Vancouver

Quinlan R, Gao H, Sinha R, Milivojevic V. Effects of the neuroactive steroid precursor pregnenolone on stress- and alcohol cue–provoked pain responses in individuals with alcohol use disorder. Experimental and Clinical Psychopharmacology. 2026. doi:10.1037/pha0000862

BibTeX
@article{Quinlan2026,
  author = {Quinlan, Riley and Gao, Huaze and Sinha, Rajita and Milivojevic, Verica},
  title = {Effects of the neuroactive steroid precursor pregnenolone on stress- and alcohol cue–provoked pain responses in individuals with alcohol use disorder},
  journal = {Experimental and Clinical Psychopharmacology},
  year = {2026},
  doi = {10.1037/pha0000862}
}
Start for free →